Unlocking Business Growth at Takeoff University
September 11, 2024 10:29 ET
|
Takeoff University
Marlton, New Jersey, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The entrepreneurial landscape thrives on innovation, but it also thrives on capital. For early-stage businesses, the dream of scaling can...
[Latest] Global Life Reinsurance Market Size/Share Worth USD 735.6 Billion by 2033 at a 12.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 01, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, July 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Life Reinsurance Market Size, Trends and Insights By Type (Facultative...
Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
April 17, 2024 13:51 ET
|
Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
Titan Environmental Solutions Inc. Announces Agreement to Purchase Standard Waste Services, LLC
January 16, 2024 08:00 ET
|
Titan Environmental Solutions Inc.
Troy, MI, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Titan Environmental Solutions Inc. ("Titan" or the "Company") (OTCQB: TESI) announced today that the Company signed a Membership Interest Purchase...
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
November 13, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
November 09, 2023 16:00 ET
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023 08:00 ET
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
LLCBuddy Releases Comprehensive Guides for LLC Formation in Any US State
April 12, 2023 09:00 ET
|
LLCBuddy
Cheyenne, WY, April 12, 2023 (GLOBE NEWSWIRE) -- With the increasing number of entrepreneurs and startups across the United States, the demand for a reliable and user-friendly guide to LLC...